Haemophilus influenzae resistance in Latin America: systematic review of surveillance data

A L de Andrade1, M C Brandileone, J L Di Fabio

  • 1Institute of Tropical Pathology and Public Health, Federal University of Goias, Brazil. ana@iptsp.ufg.br

Microbial Drug Resistance (Larchmont, N.Y.)
|February 2, 2002
PubMed

Insights

Antimicrobial resistance in Haemophilus influenzae is a concern in Latin America. Resistance to ampicillin and trimethoprim-sulfamethoxazole (TMP-SMX) was higher in noninvasive strains, with TMP-SMX resistance increasing over time.

Area of Science:

  • * Infectious Diseases
  • * Microbiology
  • * Public Health

Background:

  • * Haemophilus influenzae causes significant morbidity and mortality in children under five in developing nations.
  • * Latin America has implemented Haemophilus influenzae type b (Hib) conjugate vaccines and antimicrobial susceptibility surveillance.
  • * Antimicrobial resistance patterns are crucial for guiding effective treatment strategies.

Purpose of the Study:

  • * To systematically review and pool data on Haemophilus influenzae antimicrobial resistance in Latin America.
  • * To analyze resistance trends over a 10-year period (1990-2000) across 15 Latin American countries.
  • * To provide insights into the evolving antimicrobial resistance landscape post-Hib vaccination.

Main Methods:

  • * Systematic review and pooled analysis of published reports.
  • * Inclusion of data from 15 Latin American countries spanning 1990-2000.
  • * Analysis of antimicrobial resistance in both invasive and noninvasive Haemophilus influenzae isolates.

Main Results:

  • * Beta-lactamase production was higher in invasive (21.4%) vs. noninvasive (14.5%) isolates.
  • * Ampicillin resistance was prevalent in invasive (21.9%) and noninvasive (17.2%) strains.
  • * Trimethoprim-sulfamethoxazole (TMP-SMX) resistance was significantly higher in noninvasive (41.9%) vs. invasive (26.9%) isolates, with increasing rates in Brazil.

Conclusions:

  • * TMP-SMX resistance is more common in noninvasive isolates and shows an increasing trend in some regions.
  • * Post-Hib vaccination, an increase in nontypeable H. influenzae infections is anticipated.
  • * Continuous monitoring of H. influenzae antimicrobial resistance is essential for effective clinical management in Latin America.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...